UL Solutions Inc. ULS
NYSE · XNYS · stock · Services-Testing Laboratories · website · IPO 2024-04-12
UL Solutions Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $3.1B | $2.9B | $2.7B |
| SG&A expense | $953.0M | $931.0M | $875.0M |
| Operating income | $522.0M | $462.0M | $368.0M |
| Income tax | $125.0M | $70.0M | $70.0M |
| Net income | $325.0M | $326.0M | $260.0M |
| EPS (diluted) | $1.60 | $1.62 | $1.30 |
| Operating cash flow | $600.0M | $524.0M | $467.0M |
| Free cash flow | $403.0M | $287.0M | $252.0M |
| Cash & equivalents | $295.0M | $298.0M | $315.0M |
| Total assets | $2.9B | $2.8B | $2.7B |
| Total liabilities | $1.6B | $1.9B | $2.1B |
| Shareholders' equity | $1.3B | $931.0M | $678.0M |
Source: SEC EDGAR filings · CIK 0001901440 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.